Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.
Nat Med. 2003 Mar;9(3):294-9. Epub 2003 Feb 18.PMID: 12592403 [PubMed - indexed for MEDLINE]Related articles